||Recombinant human CLEC14A cDNA (22 – 398 aa, derived from BC031567) fused with T7-His-TEV cleavage site Tag (29aa) at N-terminal was expressed in E. coli.
||0.5 mg/ml, sterile-filtered, in 20 mM pH 8.0 Tris-HCl Buffer, with proprietary formulation of NaCl, KCl, EDTA, arginine, DTT and Glycerol.
||MASMTGGQQMGRGHHHHHHENLYFQGGEFEHPTADRAGCSASGACYSLHHATMKRQAAEEACILRGGALSTVRAG AELRAVLALLRAGPGPGGGSKDLLFWVALERRRSHCTLENEPLRGFSWLSSDPGGLESDTLQWVEEPQRSCTARR CAVLQATGGVEPAGWKEMRCHLRANGYLCKYQFEVLCPAPRPGAASNLSYRAPFQLHSAALDFSPPGTEVSALCR GQLPISVTCIADEIGARWDKLSGDVLCPCPGRYLRAGKCAELPNCLDDLGGFACECATGFELGKDGRSCVTSGEG QPTLGGTGVPTRRPPATATSPVPQRTWPIRVDEKLGETPLVPEQDNSVTSIPEIPRWGSQSTMSTLQMSLQAESK ATITPSGSVISKFNSTTSSATPQAFDSSSAV
||>90% by SDS-PAGE
||1. May be used for in vitro CLEC14A protein mediated tumor endothelial cell formation regulation study with this protein as either coating matrix protein or as soluble factor.2. May be used for CLEC14A protein – protein interaction assay.3. May be used as enzymatic substrate for various proteases.4. May be used for specific antibody production.
||Keep at -80centigrade for long term storage. Product is stable at 4 centigrade for at least 30 days.